Related Experiment Video
Updated: May 7, 2026

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.4K
Fetomaternal outcome with hepatitis e in pregnancy.
Tahira Yasmeen1, Haleema A Hashmi, Aisha Taj
1Department of Obstetrics and Gynaecology, Liaquat National Hospital, Karachi.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|October 12, 2013
Summary
Hepatitis E infection in pregnancy leads to severe maternal complications and high mortality, particularly in the third trimester. This study highlights the critical need for vigilance and management of HEV during pregnancy.
Area of Science:
- Hepatology
- Infectious Diseases
- Maternal-Fetal Medicine
Background:
- Hepatitis E virus (HEV) infection poses significant risks during pregnancy.
- Understanding HEV's impact on maternal and fetal health is crucial for clinical management.
Purpose of the Study:
- To evaluate maternal morbidity and mortality associated with Hepatitis E virus infection in pregnant women.
- To assess the fetal outcomes in pregnancies complicated by HEV.
Main Methods:
- A cross-sectional study was conducted at Liaquat National Hospital, Karachi, from May 2008 to April 2010.
- Thirty pregnant patients with serologically confirmed HEV infection were included.
- Maternal health, including liver function tests and coagulation profiles, and fetal outcomes were monitored.
Main Results:
- Maternal morbidities were most pronounced in the third trimester, with significant clinical and laboratory derangements.
- A maternal mortality rate of 29.3% (8 out of 30 patients) was observed.
- The perinatal mortality rate was 30.3 per 1000 live births.
Conclusions:
- Hepatitis E infection follows a severe course in pregnancy.
- Mortality rates are notably high, especially during the third trimester and postpartum period.
- Prompt diagnosis and management are essential for improving outcomes in HEV-infected pregnant individuals.
More Related Videos
Related Concept Videos
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
275
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K

